论文部分内容阅读
目的:观察呼吸内科住院患者肺部真菌感染的临床特征和治疗效果。方法:回顾性分析该院呼吸内科在2012年9月至2014年9月收治的38例肺部真菌感染住院患者的临床资料。结果:1本组38例患者中,存在基础疾病者36例,占总数的94.74%,其中慢性阻塞性肺病的比例为39.47%,显著高于其他基础疾病(P<0.05);2本组38例肺部真菌感染易感因素中,使用广谱抗生素32例(84.21%),使用糖皮质激素25例(65.79%),低蛋白血症13例(34.21%),化疗或放疗8例(21.05%),其他4例(10.53%);3经治疗后,本组38例患者的临床治疗总有效率为86.84%(33/38)。结论:肺部真菌感染基础疾病以慢性阻塞性肺病为主,且其易感因素较多,应积极采取抗真菌药物予以治疗。
Objective: To observe the clinical features and therapeutic effects of pulmonary fungal infection in respiratory patients in residency. Methods: The clinical data of 38 hospitalized patients with pulmonary fungal infection admitted to our hospital from September 2012 to September 2014 were retrospectively analyzed. Results: 1 of the 38 patients, there are 36 cases of underlying diseases, accounting for 94.74% of the total, of which chronic obstructive pulmonary disease was 39.47%, significantly higher than other underlying diseases (P <0.05); 2 38 Cases of pulmonary fungal infection susceptibility factors, the use of broad-spectrum antibiotics in 32 patients (84.21%), 25 cases of glucocorticoid (65.79%), hypoproteinemia in 13 cases (34.21%), chemotherapy or radiotherapy in 8 cases (21.05 %), The other 4 cases (10.53%); 3 after treatment, the total effective rate of 38 cases in this group was 86.84% (33/38). Conclusion: The basic diseases of pulmonary fungal infection are mainly chronic obstructive pulmonary disease, and the predisposing factors are more. Antifungal drugs should be actively taken for treatment.